<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890184</url>
  </required_header>
  <id_info>
    <org_study_id>1401</org_study_id>
    <nct_id>NCT04890184</nct_id>
  </id_info>
  <brief_title>Grape Juice and Dermatitis in Breast Cancer</brief_title>
  <official_title>The Effect of Grape Juice Consumption on Radiotherapy-induced Dermatitis in Breast Cancer - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Nutrition and Food Technology Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Nutrition and Food Technology Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to investigate the effect of grape juice on acute radiation dermatitis in&#xD;
      breast cancer (BC) patients undergoing radiotherapy (RT). 50 eligible BC patients will&#xD;
      randomly assign to consume 100 gr of grape juice per day during and 1 week after RT or with&#xD;
      no intervention (control group). The radiation dermatitis will be assessed weekly according&#xD;
      to the Radiation Therapy Oncology Group/ European Organization for Research and Treatment of&#xD;
      Cancer (RTOG/EORTC) scales.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dietary intake of patients will be examined by expert dietitians at baseline and end of RT&#xD;
      using the average of three-day 24-hour recalls. Weight (kg), body fat percentage, skeletal&#xD;
      muscle percentage and visceral fat level will be measured using the OMRON Body Composition&#xD;
      Monitor and Scale.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 8, 2021</start_date>
  <completion_date type="Anticipated">July 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>severity of dermatitis</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change from Baseline severity at 4 weeks. The radiation dermatitis will be assessed according to the Radiation Therapy Oncology Group/ European Organization for Research and Treatment of Cancer (RTOG/EORTC) scales</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>grape juice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>100 g of grape juice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no dietary intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>grape juice</intervention_name>
    <description>grape juice</description>
    <arm_group_label>grape juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>no intervention</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women with Brest Cancer undergoing adjutant Radiation therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous history of RT, MRM,&#xD;
&#xD;
          -  concomitant presence of two or more malignant tumors&#xD;
&#xD;
          -  metastasis to other areas&#xD;
&#xD;
          -  allergy or intolerance to tahini&#xD;
&#xD;
          -  skin diseases and wounds&#xD;
&#xD;
          -  severe liver and renal disease&#xD;
&#xD;
          -  autoimmune diseases&#xD;
&#xD;
          -  pregnant and lactating women&#xD;
&#xD;
          -  those who treated with hypo fraction RT&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 5, 2021</study_first_submitted>
  <study_first_submitted_qc>May 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 15, 2021</last_update_submitted>
  <last_update_submitted_qc>May 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Nutrition and Food Technology Institute</investigator_affiliation>
    <investigator_full_name>Dr Azita Hekmatdoost</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

